Month: July 2025

Asahi Kasei Life Science, a division of Japan-based Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki. The facility will be…

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched biotechs fare? Johnson & Johnson kicked of biopharma’s Q2 season last week, beating…

Lonza reported a solid start to the first half of 2025 on Wednesday, with strong overall performance by its contract development and manufacturing organization (CDMO) business including positive momentum in mammalian, bioconjugates,…

Cambridge, U.K.-based drugmaker AstraZeneca announced that it will invest $50 billion in manufacturing and R&D in the United States by 2030, as the company looks to reach its goal of $80 billion…

Biogen, a biotechnology company based in Cambridge, Massachusetts, said it will invest an additional $2 billion to expand its pharmaceutical manufacturing operations in North Carolina’s Research Triangle Park (RTP). The investment will…

With fewer biopharma companies performing all their manufacturing in-house, CDMOs provide much-needed, at-scale production capacity, as well as outsourced services such as drug development and testing to reduce costs and…